Publication | Closed Access

Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

Neoadjuvant TherapySquamous Cell CarcinomaMedicineHead And Neck CancerCancer TreatmentNeck OncologyOncologyRadiation OncologyPhase 3RadiologyHealth Sciences